SCHEMBL755068

SCHEMBL755068

NOCCCON

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3501982 0.95
Hydrochloric Acid SCHEMBL9185099 0.95
SCHEMBL756020 0.90
SCHEMBL2223228 0.86 ODC1 (0.60)
SCHEMBL21357744 0.86 ODC1 (0.60)
Hydrochloric Acid SCHEMBL9191751 0.86
SCHEMBL21357864 0.86 ODC1 (0.60)
SCHEMBL10776208 0.86 ODC1 (0.60)
SCHEMBL9185840 0.86
SCHEMBL1039109 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129340-A1 HYDROGELS FOR ORGANOID CULTURE ACADEMISCH ZIEKENHUIS MAASTRICHT (NL) 2025-04-24 US claimed
EP-4426752-A1 HYDROGELS FOR ORGANOID CULTURE Universiteit Maastricht (NL) 2024-09-11 EP claimed
WO-2023073244-A1 HYDROGELS FOR ORGANOID CULTURE UNIVERSITEIT MAASTRICHT (NL) 2023-05-04 WO claimed
US-20160355859-A1 TRANSGLUTAMINASE MEDIATED CONJUGATION OF PEPTIDES NOVO NORDISK A/S (DK) 2016-12-08 US claimed
EP-2033662-B1 Transglutaminase mediated conjugation of peptides NOVO NORDISK HEALTHCARE AG (CH) 2012-10-17 EP claimed
EP-2368579-A1 Transglutaminase mediated conjugation of peptides Novo Nordisk Health Care AG (CH) 2011-09-28 EP claimed
US-20100197573-A1 Transglutaminase Mediated Conjugation of Growth Hormone NOVO NORDISK HEALTH CARE AG (CH) 2010-08-05 US claimed
US-20100009917-A1 Modulating Enzymatic Processes by Addition of Diolcontaining Substances NOVO NORDISK HEALTH CARE AG (CH) 2010-01-14 US claimed
US-20090264366-A1 Transglutaminase Mediated Conjugation of Peptides NOVO NORDISK HEALTHCARE AG (CH) 2009-10-22 US claimed
EP-2033662-A1 Transglutaminase mediated conjugation of peptides Novo Nordisk Health Care AG (CH) 2009-03-11 EP claimed
US-20070105770-A1 Transglutaminase mediated conjugation of peptides NOVO NORDISK A/S (DK) 2007-05-10 US claimed
EP-0516074-B1 Aqueous dispersions of carbonylgroup-containing copolymers, further containing aminoxy-curing agents WACKER CHEMIE GMBH (DE) 1995-09-27 EP claimed
US-5278225-A Comprising (meth)acrylates of alcohol monomer WACKER-CHEMIE GMBH (DE) 1994-01-11 US claimed
EP-0516074-A1 Aqueous dispersions of carbonylgroup-containing copolymers, further containing aminoxy-curing agents WACKER-CHEMIE GMBH (DE) 1992-12-02 EP claimed
US-20250375530-A1 ROR1/EGFR BI-SPECIFIC ANTIGEN BINDING MOLECULES ALMAC DISCOVERY LTD (GB) 2025-12-11 US disclosed
US-20250295767-A1 ROR1-SPECIFIC ANTIGEN BINDING MOLECULES ALMAC DISCOVERY LIMITED (GB) 2025-09-25 US disclosed
US-20250269051-A1 ROR1-SPECIFIC VARIANT ANTIGEN BINDING MOLECULES ALMAC DISCOVERY LIMITED (GB) 2025-08-28 US disclosed
EP-0516074-B1 Aqueous dispersions of carbonylgroup-containing copolymers, further containing aminoxy-curing agents WACKER CHEMIE GMBH (DE) 1995-09-27 EP disclosed
US-5278225-A Comprising (meth)acrylates of alcohol monomer WACKER-CHEMIE GMBH (DE) 1994-01-11 US disclosed
EP-0516074-A1 Aqueous dispersions of carbonylgroup-containing copolymers, further containing aminoxy-curing agents WACKER-CHEMIE GMBH (DE) 1992-12-02 EP disclosed